Personal tools

MCL coexpression mm9:1318: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0000064!6.96e-15!99;UBERON:0002020!3.75e-13!34;UBERON:0006562!6.57e-13!24;UBERON:0001557!6.57e-13!24;UBERON:0001042!6.57e-13!24;UBERON:0008814!6.57e-13!24;UBERON:0009145!6.57e-13!24;UBERON:0002370!9.86e-13!23;UBERON:0000974!9.86e-13!23;UBERON:0004807!9.86e-13!23;UBERON:0005058!9.86e-13!23;UBERON:0003351!9.86e-13!23;UBERON:0009113!9.86e-13!23;UBERON:0003295!9.86e-13!23;UBERON:0009722!9.86e-13!23;UBERON:0005562!9.86e-13!23;UBERON:0007690!9.86e-13!23;UBERON:0003408!7.57e-12!24;UBERON:0003528!1.85e-11!29;UBERON:0002791!1.85e-11!29;UBERON:0001893!1.85e-11!29;UBERON:0000072!1.64e-10!27;UBERON:0004177!2.39e-10!29;UBERON:0005057!2.39e-10!29;UBERON:0000956!4.38e-10!21;UBERON:0001869!4.38e-10!21;UBERON:0000203!4.38e-10!21;UBERON:0002780!1.12e-08!39;UBERON:0001890!1.12e-08!39;UBERON:0006240!1.12e-08!39;UBERON:0000153!1.22e-08!43;UBERON:0007811!1.85e-08!36;UBERON:0003080!3.15e-08!40;UBERON:0000077!8.20e-08!35;UBERON:0000073!1.31e-07!54;UBERON:0002619!2.61e-07!17;UBERON:0000063!3.85e-07!35;UBERON:0001049!4.22e-07!52;UBERON:0005068!4.22e-07!52;UBERON:0006241!4.22e-07!52;UBERON:0007135!4.22e-07!52
|ontology_enrichment_uberon=UBERON:0000064!6.96e-15!99;UBERON:0002020!3.75e-13!34;UBERON:0006562!6.57e-13!24;UBERON:0001557!6.57e-13!24;UBERON:0001042!6.57e-13!24;UBERON:0008814!6.57e-13!24;UBERON:0009145!6.57e-13!24;UBERON:0002370!9.86e-13!23;UBERON:0000974!9.86e-13!23;UBERON:0004807!9.86e-13!23;UBERON:0005058!9.86e-13!23;UBERON:0003351!9.86e-13!23;UBERON:0009113!9.86e-13!23;UBERON:0003295!9.86e-13!23;UBERON:0009722!9.86e-13!23;UBERON:0005562!9.86e-13!23;UBERON:0007690!9.86e-13!23;UBERON:0003408!7.57e-12!24;UBERON:0003528!1.85e-11!29;UBERON:0002791!1.85e-11!29;UBERON:0001893!1.85e-11!29;UBERON:0000072!1.64e-10!27;UBERON:0004177!2.39e-10!29;UBERON:0005057!2.39e-10!29;UBERON:0000956!4.38e-10!21;UBERON:0001869!4.38e-10!21;UBERON:0000203!4.38e-10!21;UBERON:0002780!1.12e-08!39;UBERON:0001890!1.12e-08!39;UBERON:0006240!1.12e-08!39;UBERON:0000153!1.22e-08!43;UBERON:0007811!1.85e-08!36;UBERON:0003080!3.15e-08!40;UBERON:0000077!8.20e-08!35;UBERON:0000073!1.31e-07!54;UBERON:0002619!2.61e-07!17;UBERON:0000063!3.85e-07!35;UBERON:0001049!4.22e-07!52;UBERON:0005068!4.22e-07!52;UBERON:0006241!4.22e-07!52;UBERON:0007135!4.22e-07!52
|tfbs_overrepresentation_for_novel_motifs=1.23219,0.0600685,0.464605,0.535892,0.346849,0.550971,0.645383,0.247459,0.257202,0.0835344,0.599767,0.632897,0.692139,0.6581,0.364314,0,0.856992,0.338549,0.232269,0.143775,1.09054,0.108444,0.657163,0.345236,0.472505,0.686615,0.223823,0.572827,0.394364,0.181062,0.558142,0.960397,0.892985,0.589948,0.364821,0.144368,0.871288,0.629145,0.820134,0.27383,0.342638,0.56353,0.0995018,0.366415,0.368882,0.524258,0.77511,0.589246,0.0835644,0.397446,0.839084,0.714419,0.995874,1.10437,1.12205,0.66551,0.406788,0.619643,0.614918,0.663395,0.939962,0.724164,0.269393,0.827522,0.677043,0.869046,1.2599,1.61148,0.935192,1.46355,0.444872,0.253541,0.11437,1.156,0.208101,0.19692,0.204132,0.763395,0.922432,0.430551,0.708505,0.874787,0.722675,2.72786,1.03903,0.198949,0.220054,0.534643,0.780154,1.77427,2.95458,1.04409,0.973447,0.9304,0.2995,0.281222,0.244935,0.976308,0.775372,0.160254,0.326561,0.960112,2.46222,0.839694,0.838613,0.563071,0.8998,0.585058,0.435642,0.428007,1.21641,1.0885,0.431734,1.47196,1.33732,0.340765,1.87959,0.53982,0.858327,0.322606,1.16147,0.805995,0.688501,0.762461,1.39185,0.926209,0.65384,0.966541,1.25836,2.52463,1.06946,0.52828,1.2285,0.679647,1.35909,0.106956,0.500709,1.38743,1.30952,2.14327,1.74232,1.26465,0.700956,0.971067,0.831964,0.564002,0.778321,2.10357,0.503174,0.348692,0.183562,0.325363,1.10596,0.287383,0.678689,1.18867,0.71546,0.376898,0.48935,0.500417,1.31911,1.03816,0.926663,0.482185,0.82857,0.671017,0.86867,0.63125,0.0323861
}}
}}

Revision as of 19:43, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr12:109150860..109150875,-p@chr12:109150860..109150875
-
Mm9::chr12:109151709..109151720,-p@chr12:109151709..109151720
-
Mm9::chr12:109151814..109151819,-p@chr12:109151814..109151819
-
Mm9::chr12:109241804..109241823,-p5@Bcl11b
Mm9::chr12:109241852..109241873,-p4@Bcl11b
Mm9::chr12:109241897..109241915,-p6@Bcl11b


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:




Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>

Uber Anatomy
Ontology termp-valuen
organ part6.96e-1599
gray matter3.75e-1334
pharynx6.57e-1324
upper respiratory tract6.57e-1324
chordate pharynx6.57e-1324
pharyngeal arch system6.57e-1324
pharyngeal region of foregut6.57e-1324
thymus9.86e-1323
neck9.86e-1323
respiratory system epithelium9.86e-1323
hemolymphoid system gland9.86e-1323
pharyngeal epithelium9.86e-1323
thymic region9.86e-1323
pharyngeal gland9.86e-1323
entire pharyngeal arch endoderm9.86e-1323
thymus primordium9.86e-1323
early pharyngeal endoderm9.86e-1323
gland of gut7.57e-1224
brain grey matter1.85e-1129
regional part of telencephalon1.85e-1129
telencephalon1.85e-1129
segment of respiratory tract1.64e-1027
hemopoietic organ2.39e-1029
immune organ2.39e-1029
cerebral cortex4.38e-1021
cerebral hemisphere4.38e-1021
pallium4.38e-1021
regional part of forebrain1.12e-0839
forebrain1.12e-0839
future forebrain1.12e-0839
anterior region of body1.22e-0843
craniocervical region1.85e-0836
anterior neural tube3.15e-0840
mixed endoderm/mesoderm-derived structure8.20e-0835
regional part of nervous system1.31e-0754
regional part of cerebral cortex2.61e-0717
organ segment3.85e-0735
neural tube4.22e-0752
neural rod4.22e-0752
future spinal cord4.22e-0752
neural keel4.22e-0752


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=MCL_coexpression_mm9:1318&oldid=2562538"